Publication date: Oct 16, 2025
We hypothesize that a unified mitochondrial perspective on aging, HIV, and long COVID reveals shared pathogenic mechanisms and specific therapeutic vulnerabilities that are overlooked when these conditions are treated independently. Mitochondrial dysfunction is increasingly recognized as a common factor driving aging, HIV, and long COVID. Shared mechanisms-including oxidative stress, impaired mitophagy and dynamics, mtDNA damage, and metabolic reprogramming-contribute to ongoing energy failure and chronic inflammation. Recent advancements highlight new therapeutic strategies such as mitochondrial transfer, transplantation, and genome-level correction of mtDNA variants, with early preclinical and clinical studies providing proof-of-concept. This review summarizes current evidence on mitochondrial changes across aging and post-viral syndromes, examines emerging organelle-based therapies, and discusses key challenges related to safety, durability, and translation.
Open Access PDF
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Mitochondrial Dysfunction |
| disease | MESH | Long COVID |
| disease | MESH | oxidative stress |
| pathway | REACTOME | Mitophagy |
| disease | MESH | inflammation |
| disease | MESH | syndromes |
| pathway | REACTOME | Translation |